Anbio Biotechnology

Anbio Biotechnology (Anbio) is a globally leading medical device company specializing in in vitro diagnostics. The company aims to revolutionize the diagnostic market by personalizing and decentralizing current diagnostic solutions, enabling rapid diagnosis and improved patient outcomes. Anbio achieves this by providing cutting-edge laboratory, health, home, and point-of-care testing (POCT) in vitro diagnostic (IVD) solutions that are fast, convenient, and affordable worldwide. Anbio Biotechnology's extensive product portfolio includes a range of IVD products designed to meet diverse diagnostic needs. Anbio’s comprehensive product line covers solutions for various applications, including over-the-counter (OTC) use, point-of-care testing (POCT) settings, and laboratory applications. Anbio’s IVD products are designed to detect a variety of biomarkers associated with critical medical fields. Since its establishment, Anbio Biotechnology has been committed to providing customers with state-of-the-art diagnostic solutions while ensuring cost-effectiveness. Anbio possesses extensive capabilities in research and development, manufacturing, and global product distribution logistics, enabling the company to continuously focus on reducing costs while delivering a variety of well-established laboratory diagnostics and point-of-care testing (POCT) technology products. Anbio Biotechnology's product range covers infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, kidney diseases, pharmacogenomics, and diabetes. By offering advanced diagnostic capabilities in these areas, Anbio empowers healthcare professionals to identify and monitor various conditions, facilitating timely intervention and patient care.